Stocks
Should You Invest in Nvidia or AMD Stock Following Their New AI Platform Launches?
Nvidia and AMD presented their latest AI technologies during the Consumer Electronics Show (CES) held in Las Vegas from January 6-9, 2026. Nvidia launched ...
McCormick Acquires Majority Stake in Mexico Joint Venture: A Strategy for Growth in 2026?
McCormick & Company, Inc. (MKC) has acquired an additional 25% ownership interest in McCormick de Mexico for $750 million, increasing its stake to 75% ...
Daily Downtrend Report: HP Inc. (HPQ)
HP Inc. is facing a challenging outlook for fiscal 2026, with management forecasting a decline in PC unit volumes due to changes in customer ...
Two Stocks Set to Outperform NVIDIA by 2025 with Promising Future Growth
Despite ongoing U.S.-China trade tensions, NVIDIA Corporation (NVDA) reported robust quarterly results throughout 2025, driven by the booming demand for artificial intelligence (AI) technology. ...
Home Depot’s Innovative Pro Tools: A Game Changer for Major Project Success?
Home Depot, Inc. has introduced new digital tools aimed at enhancing project planning and bidding for contractors. Launched in September 2025, a project planning ...
Top AI Stocks Expected to Thrive in the January Market Boost
U.S. stocks are positioned for a potential January rally despite recent declines, primarily influenced by the seasonality known as the “January Effect” and motivated ...
Evaluating AIZ Near 52-Week High: Is It the Right Moment for Investment?
Shares of Assurant, Inc. (AIZ) closed at $240.85 on Wednesday, nearing its 52-week high of $243.76. The stock has risen 24.5% over the last ...
Top 3 Stocks for Quantum Investing Success in 2026
The global quantum computing market is projected to grow from $0.8 billion in 2025 to $1.08 billion in 2026, with a compound annual growth ...
RARE Advances with Successful Completion of AAV Gene Therapy Submission
Ultragenyx Pharmaceutical (RARE) saw a 15.5% stock increase following the completion of a rolling submission of a biologics license application (BLA) to the FDA ...
Evaluating PLTR’s ROE: Insights into Sustainable Efficiency Growth
Palantir Technologies Inc. (PLTR) reported a return on equity (ROE) of 27.6%, slightly below the industry average of 33.25%. The company focuses on long-cycle ...
